FKBP9P1

Across TCGA pan-cancer cohorts, FKBP9P1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of FKBP9P1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where FKBP9P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FKBP9P1 is over-expressed in tumor, although a few such as UCEC and PRAD show the opposite, repressed pattern.

HNSC, COAD, and LIHC are the cancer types where FKBP9P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FKBP9P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Female	IV	+1.876	<.001	12	view →
COAD	All	II,III,IV	+0.655	<.001	9	view →
LIHC	All	All	+0.324	<.001	7	view →
KIRC	Male	All	+0.861	<.001	6	view →
UCEC	All	All	−0.586	.002	6	view →
CHOL	All	All	+0.600	.001	5	view →
STAD	Male	All	+0.766	.004	4	view →
LUSC	Male	All	+0.956	<.001	3	view →
PRAD	All	All	−0.478	<.001	2	view →
READ	All	All	+0.475	.025	1	view →
LUAD	All	All	+0.372	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

FKBP9P1–HNSC

Open the HNSC breakdown →